ARTICLE
10 April 2026

Regulatory Horizons: Supply Chain Sovereignty: How U.S. And EU Regulatory Priorities Are Reshaping Life Sciences Manufacturing (Podcast)

B
BakerHostetler

Contributor

Recognized as one of the top firms for client service, BakerHostetler is a leading national law firm that helps clients around the world address their most complex and critical business and regulatory issues. With five core national practice groups — Business, Labor and Employment, Intellectual Property, Litigation, and Tax — the firm has more than 970 lawyers located in 14 offices coast to coast. BakerHostetler is widely regarded as having one of the country’s top 10 tax practices, a nationally recognized litigation practice, an award-winning data privacy practice and an industry-leading business practice. The firm is also recognized internationally for its groundbreaking work recovering more than $13 billion in the Madoff Recovery Initiative, representing the SIPA Trustee for the liquidation of Bernard L. Madoff Investment Securities LLC. Visit bakerlaw.com
In Washington, supply chains are now tied to national security, resilience, and public health. We’re seeing that play out in FDA policy, inspection priorities, and legislation like the BIOSECURE Act.
United States Food, Drugs, Healthcare, Life Sciences
Winston S. Kirton’s articles from BakerHostetler are most popular:
  • within Food, Drugs, Healthcare and Life Sciences topic(s)
  • in United States
  • with readers working within the Healthcare industries

1771420a.jpg

In Washington, supply chains are now tied to national security, resilience, and public health. We’re seeing that play out in FDA policy, inspection priorities, and legislation like the BIOSECURE Act.

Across the Atlantic, the story is similar—but not identical. The European Union is advancing its own framework through the Critical Medicines Act, shortage‑prevention mandates, and new expectations around manufacturing resilience.

The result is a new reality for global companies: U.S. and EU regulators are aligned in objective, but increasingly divergent in execution.

Today, we’re going to unpack what that means in practice—how onshoring, friend‑shoring, and supply‑chain sovereignty are reshaping compliance, approvals, and enforcement on both sides of the Atlantic. Questions and Comments: wkirton@bakerlaw.com

Download Episode Transcript

View All Episodes

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More